Galmed Pharmaceuticals (GLMD) has released an update.
Galmed Pharmaceuticals Ltd. has announced a reverse stock split at a ratio of 1-for-12, effective after market close on August 29, 2024. Post-split, the company will have approximately 632,889 ordinary shares with a par value of NIS 1.80 each. The adjustment will also affect the exercise price and number of shares available through existing options.
For further insights into GLMD stock, check out TipRanks’ Stock Analysis page.
